CANAGLIFLOZIN

Clinical Indication

Type 2 diabetes

Comments

Conditional on prescriber being competent to select appropriate patients.

Local guidance

Use in line with NICE TA 315 only where dapagliflozin not suitable.

National guidance

NICE TA 315 

Date of classification

December 2014

Review date

December 2017

Green CONDITIONAL

Drugs for which GPs are able to take full responsibility for prescribing and monitoring subject to specified conditions e.g. prescribing in line with agreed LMSG guidance or able to demonstrate suitable competence see comments under individual entries.